What could follow, and what has to be true first.
The Prevention Adoption Initiative starts with one colorectal cancer screening pilot in a Michigan health center. Every later stage waits on that pilot’s evaluation. Nothing here has a date, because none of it has a credible schedule yet.
- Stage 1 · ProposedSee the pilot →
The first pilot
One health center, three transparent ranking rules, the site’s own staff. Three months of feasibility at no fee, then a funded pilot to month twelve.
- Gate · decision pointProposed criteria, not agreed thresholds
Go further only if the pilot shows…
BenefitAgainst the site’s own trendFeasibilityStaff can run it week to weekStaff burdenNo extra load that cannot lastData qualityThe nightly file arrives complete and on timeEquityThe gap between language groups does not widenResourcesA lasting way to pay for staff time - Stage 2 · Requires evaluation
What leaves the pilot
By month twelve the routine is written down and handed to the site’s staff. The written part is what can travel to another clinic. None of it exists yet; each item is something the first pilot is designed to produce.
The toolkit
What the pilot would hand over- The weekly routine, written as a manual the quality-improvement lead can run.
- The 19-column data specification and the checks on the nightly file.
- The scripts, letters and texts, in the site’s languages, each with the barrier it was written to overcome.
- The list of reasons people stalled, as found, and the response that worked for each.
- The worklist template and its three rules.
- The training package for outreach staff.
- The evaluation plan (RE-AIM) and its measures, including cost per completed screening and staff hours per completion.
Must be true firstThe gate passed, and the site agrees what can be shared.
How it would travel
Who would carry it- Health-center networks and primary care associations, Michigan first.
- Public-health training centers and MPH programs, as a teaching case.
- The academic partner’s publication, whichever way the result goes.
- Medicaid managed-care and value-based-care organizations whose contracts already tie payment to colorectal screening and would tie it to follow-up after a positive test if NCQA’s proposed COF-E measure is adopted for 2027.
Must be true firstA second site willing to run it from the written toolkit, which is Stage 3.
- Stage 3 · Requires evaluation
Possible expansion
A second clinic
What would changeThe same routine at another health center.
Problem it would solveOne site cannot show that the result travels.
Must be true firstThe gate passed, plus a host and an evaluator for the second site.
Deeper EHR integration
What would changeA direct EHR connection in place of the nightly coded file.
Problem it would solveManual exports and a one-day lag.
Must be true firstA business associate agreement, a HIPAA-eligible setup, and the site’s IT sign-off.
- Stage 4 · Future possibility
Possible advanced capabilities, each with its own conditions
Predictive prioritization
What would changeA model suggests who is least likely to finish, next to the rules.
Problem it would solveSome patients at risk of not finishing do not stand out on days overdue alone.
Must be true firstThe rules evaluated, enough outcome data, a fairness audit, staff still deciding, and a model that beats the rules.
Conversational outreach
What would changeTwo-way text reminders in the patient’s language that help book the test.
Problem it would solveStaff time spent on routine reminders instead of the hard cases.
Must be true firstThe site’s consent process, a BAA, and a tested hand-off to a person. Nothing automated before then.
Equity monitoring
What would changeRegular checks that outreach is not reaching easier patients first.
Problem it would solveAutomation can widen the gap between language or payer groups.
Must be true firstA review board, agreed measures, and enough patients in each group to read.
- Stage 5 · Future possibility
Local adaptation: other screenings, other health systems
The same routine could run on other recommended steps that people start and do not finish, and in other health systems. Five are sketched below. Each would need its own local design and validation.
Illustrative · five other finish linesSame four steps, same division of work: your staff act, HSREP keeps the list, an independent evaluator judges. Each line below is a recommended step that people start and do not finish, with the published size of the gap. Pick one.
Finish lineA repeat reading and a plan within four weeks of a high reading (CMS measure 22, screening for high blood pressure and follow-up).
The gap30.5%
of patients whose readings met the hypertension threshold had no recorded diagnosis during the study, and another 14.6% were diagnosed late. One health system, 311,743 patients, 2010 to 2021.
Lu, Brush et al., JAMA Network Open 2025.
- 01 · Find
Everyone with a reading of 140/90 or above and no recheck on the books, from the nightly file.
- 02 · Rank
Days since the high reading, how high it was, prior no-shows.
- 03 · Act
A nurse blood-pressure visit, a loaned home cuff with a call-back, or a pharmacist visit.
- 04 · Close
A diagnosis made or ruled out, and the days from the first high reading to that decision.
Invented patientRosa M. · two readings at 140/90 or above · 61 days, no recheck booked → nurse BP visit booked, cuff lent, call-back in a week.
Finish lineA retinal exam within the year for every adult with diabetes (HEDIS measure EED).
The gap54.1%
of Medicare beneficiaries with diabetes had an eye exam in 2017. Healthy People 2030 puts the national baseline at 64.8% and the target at 70.3%.
Lundeen et al., MMWR 2019; Healthy People 2030 objective D-04.
- 01 · Find
Everyone with diabetes and no eye exam in the last twelve months.
- 02 · Rank
Months since the last exam, a known retinopathy history, prior no-shows.
- 03 · Act
A retinal photo at the clinic if it has a camera, or a booked eye appointment with a ride.
- 04 · Close
The exam result in the chart, and the days it took.
Invented patientDmitri K. · last eye exam 23 months ago · one prior no-show → retinal photo added to the visit already booked next week.
Finish lineBoth kidney tests, a blood test (eGFR) and a urine test (uACR), within the year (HEDIS measure KED).
The gapUnder 40%
of adults with diabetes received both tests in 2017. The urine test is the one that gets missed. Seven million adults, insurance claims data.
Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2023.
- 01 · Find
Everyone with diabetes missing either test in the last twelve months.
- 02 · Rank
Months since the last urine test, whether a blood draw is already scheduled, prior no-shows.
- 03 · Act
Add the urine test to a lab order that already exists, or a lab-only visit with no appointment.
- 04 · Close
Both results in the chart.
Invented patientAmina S. · blood test done, no urine test in 14 months → urine test added to the lab order already scheduled for Thursday.
Finish lineDiagnostic imaging or a biopsy within 60 days of an abnormal screening mammogram (BI-RADS 0, 4 or 5; measure PQM 4700e).
The gap66.4%
of 2.9 million abnormal (BI-RADS 0) screening mammograms from 2008 to 2021 had documented diagnostic follow-up. A third did not.
2024 study cited in the Brigham and Women’s measure submission, PQM 4700e.
- 01 · Find
Every abnormal screening result with no diagnostic imaging or biopsy recorded.
- 02 · Rank
Days since the result, the BI-RADS category (4 and 5 first), prior no-shows.
- 03 · Act
A booked diagnostic appointment, a navigator call, a ride.
- 04 · Close
The diagnostic result in the chart (benign, probably benign, or biopsy done), and the days.
Invented patientGrace O. · BI-RADS 0 · 48 days, nothing booked → diagnostic ultrasound booked, ride arranged, result back in the chart on day 57.
Finish lineA colposcopy after an abnormal result that calls for one. Guidelines expect it within months; the study below allowed a year.
The gap75.3%
received a colposcopy within twelve months of the abnormal result. One in four did not, even with a year. 28,706 patients, 2010 to 2018.
Kamineni, Feldman et al., Preventive Medicine 2022 (PROSPR).
- 01 · Find
Every abnormal result that calls for colposcopy, with none recorded.
- 02 · Rank
Days since the result, the grade of the result (high-grade first), prior no-shows.
- 03 · Act
A call in the patient’s language, a booked colposcopy, help with childcare or transport.
- 04 · Close
Colposcopy done, and the days from result to procedure.
Invented patientLan T. · high-grade result · 95 days, no colposcopy → called in Vietnamese, booked, reminder two days before.
Nothing here is proposed as a pilot. Colorectal screening is the only pilot being asked for. The patients are invented and the gap figures come from the sources named, not from any HSREP work. Each line would need its own local design, evidence review and evaluation before anyone ran it.
Partners who could matter · prospective, none confirmedWhere it would runMore health centers after the Michigan pilot, through health-center networks and professional bodies.
StatusAfter the pilot is evaluated.
Health system / Pop. health · U.S.Why youYour population-health team owns HEDIS COL and value-based targets, and soon, follow-up-after-positive completion.DifferentThe loop instruments execution (who was reached, what closed) not just outcomes, so gains hold across sites.Health plan / MCO · U.S.Move the measure you're already paid on
Why youColorectal cancer screening (COL) has been in the CMS Medicaid Adult Core Set since 2022, and managed-care contracts commonly tie Core Set performance to a quality withhold or incentive payment. NCQA has proposed the follow-up measure itself (COF-E, HEDIS MY2027: colonoscopy within 180 days of a positive test).DifferentA published mailed-FIT cost benchmark, $54.83 direct per patient screened (Pignone 2021), equity-stratified, run inside your network's clinics.Association / CoalitionBring a measurable completion model to your members
Why youYour member sites report these measures, and most face the same completion gap.DifferentA turnkey, evidence-based package members run inside existing staffing, with the weekly checks included.Community memberFor patients: care that actually reaches you
Why youThis work exists so recommended care actually reaches people, with dignity, in plain language.DifferentYour data is not sold or exploited, decisions can be explained, and the limits are stated plainly.Where it would runCommunity clinics under the national cervical and breast screening program, and private diagnostic networks.
StatusA future direction, in development.
United StatesBangladeshWhere it runsOne Southeast Michigan health center, colorectal cancer screening first.Community clinics under the national cervical and breast screening program.What already existsUDS reporting, a FHIR-capable EHR, and an outreach function the site already staffs.Roughly 14,000 community clinics as of 2019, and a national electronic registry.Where it leaksScreening gets counted, but a positive test is not always followed to colonoscopy.Low uptake and loss to follow-up, reported by the program’s own evaluation.StatusThe first pilot, on the main page.A future direction, in development.Different partners, different value, same routine
Organizations named here are prospective. None is a confirmed partner.PRIVATE HEALTHCAREWhere completion is also good business
For a private network, a natural first partner, higher completion compounds commercially: more screenings lead to more diagnostics, more appropriate downstream care, stronger patient retention, and better-positioned corporate-wellness and payer contracts. The initiative raises the completion rate the business is already working to grow, advancing patient health and commercial performance together.
GOVERNMENTStrengthening a program that already exists
For the DGHS Non-Communicable Disease Control Programme (NCDC), the national cervical & breast screening leadership, and the Community Clinic Health Support Trust, the completion loop embeds into the existing network of roughly 14,000 community clinics as of 2019 and the national electronic registry, closing the uptake and follow-up gaps the program’s own evaluation identifies, piloted in a few upazilas and aligned to the national strategy.
RESEARCH & NGOReach, rigor, and credibility
BRAC and Marie Stopes bring community reach; icddr,b, BSMMU, and NICRH bring evaluation and clinical authority. Together, these partners can turn a pilot into publishable, scalable evidence, and open pathways to both government and donor funding.
Private network · BangladeshFinish the tests you already start
Why youYou already run entry-level test campaigns. The leak is conversion: price shock at the next step, urgency that never lands, and second-visit logistics.DifferentThe loop attacks all three: transparent bundled next-step pricing, literacy-tailored urgency communication, one-visit and home-collection logistics. An operational lesson from inside a private network: coverage alone doesn't complete care; a designed loop does.Public program · BangladeshStrengthen a program that already exists
Why youBangladesh's national screening program has reach and a registry (roughly 14,000 community clinics on e-HIS as of 2019) yet its own evaluation found only 40.4% of VIA-positive women attended for colposcopy between January 2018 and May 2023 (Nessa et al., BMC Global and Public Health 2025;3:34).DifferentEmbed, don't build: the completion loop plugs into the registry and clinics you already run, DGHS NCDC, NCCBCST, and the Community Clinic Health Support Trust, piloted in a few upazilas.Experience in one setting does not show that the routine will work in another. Where the work could begin abroad is where I already have standing and screening-service experience; that is a reason to start there, not evidence that it will work there.
- 01 · Find
All of this depends on the first pilot.
If your organization could host it, that is the conversation to have first.
An HSREP initiative in development. Everything on this page is future direction and illustrative; no patient data has been collected.